基因預測工具市場規模、佔有率和成長分析：按方法論、應用、最終用途、技術整合、銷售管道和地區分類－2026-2033年產業預測

2024 年全球基因預測工具市值為 4.825 億美元，預計從 2025 年的 5.5101 億美元成長到 2033 年的 15.94 億美元，預測期（2026-2033 年）的複合年成長率為 14.2%。

全球基因預測工具市場主要受基因組數據激增和對可操作生物學見解的需求所驅動，加速了企業級生物資訊解決方案的轉型。這些工具，包括用於識別編碼區、剪接位點和轉錄本結構的高級演算法，對於增強藥物發現、臨床診斷和農作物改良至關重要。該領域正從傳統的預測方法朝向利用機器學習和雲端技術的複雜、主導方法演進，從而實現更精準的預測。準確性的提高，加上定序成本的下降和雲端功能的擴展，正在推動擴充性的軟體即服務 (SaaS) 模型以及與多組體學平台的整合。因此，臨床和工業領域的成長和應用正在加速。

全球基因預測工具市場促進因素

全球基因預測工具市場的發展主要得益於機器學習演算法的顯著進步，這些進步提高了基因預測工具在識別編碼區、剪接位點和調控元件方面的準確性。這些創新增強了模式識別能力，提高了模型的泛化能力，從而最大限度地減少了假陽性結果，並提高了模型在不同基因組中的適應性。此外，整合序列上下文和演化訊號等多種資料類型的能力，使得預測結果更加穩健。隨著這些演算法的不斷改進，開發人員將更容易提供滿足科學研究和臨床工作流程需求的工具，從而促進其在生物資訊流程中更廣泛的應用和整合。

全球基因預測工具市場面臨的限制因素

基因預測工具的普及應用受到資料隱私和監管挑戰的阻礙。管理高度敏感的基因組資訊的嚴格標準給開發者和使用者都帶來了沉重的合規負擔。這導致在知情同意、資料共用和跨境資料傳輸方面存在不確定性，使得機構對採用新的預測技術猶豫不決。遵守各種法律體制往往會分散創新資源。這些義務可能導致產品發布延遲、夥伴關係複雜化、限制對開發高級預測模型所需關鍵資料集的訪問，並最終阻礙市場成長和發展。

基因預測工具市場的全球趨勢

全球基因預測工具市場日益受到人工智慧可解釋性需求成長的驅動，這增強了人們對基因組研究和臨床應用的信心。這些工具優先考慮模型的可解釋性，使研究人員和臨床醫生能夠理解決策流程，從而提高突變優先排序和治療方案選擇的信心。這一趨勢促進了計算科學家和實驗研究人員之間的合作，有助於與監管機構進行清晰的溝通，並簡化了與診斷工作流程的整合。透過特徵歸因分析和使用者友善的視覺化來提高透明度，可以降低黑箱模型帶來的風險，從而擴大這些工具在轉化研究和臨床結果方面的效用。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球基因預測工具市場規模：依方法分類

• 實證方法
• 阿布伊尼蒂奧律師事務所
• 基於同源性的方法
• 其他

全球基因預測工具市場規模：依應用領域分類

• 藥物發現與開發
• 診斷發展
• 農業生物技術
• 其他

全球基因預測工具市場規模：依最終用途分類

• 學術研究機構
• 製藥和生物技術公司
• 工業和農業相關企業
• 其他

全球基因預測工具市場規模：按技術整合分類

• 人工智慧和機器學習工具
• 標準生物資訊學工具
• 其他

全球基因預測工具市場規模：依銷售管道分類

• 軟體直銷
• 基於雲端的服務平台
• 其他

全球基因預測工具市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• NCBI
• Ensembl
• EBI（European Bioinformatics Institute）
• Illumina
• Thermo Fisher Scientific
• Qiagen
• DNASTAR
• Geneious
• Softberry
• Genedata
• Bio-Rad Laboratories
• LabCorp
• Myriad Genetics
• 23andMe
• Counsyl
• BGI Genomics
• Eurofins Scientific
• Agilent Technologies
• Oxford Nanopore Technologies
• PacBio

結論與建議

Global Gene Prediction Tools Market size was valued at USD 482.5 Million in 2024 and is poised to grow from USD 551.01 Million in 2025 to USD 1594.0 Million by 2033, growing at a CAGR of 14.2% during the forecast period (2026-2033).

The global gene prediction tools market is significantly influenced by the rapid increase in genomic data and the demand for actionable biologic insights, prompting a transition towards enterprise-grade bioinformatics solutions. These tools, which include advanced algorithms designed to pinpoint coding regions, splice sites, and transcript structures, are crucial for enhancing drug discovery, clinical diagnostics, and agricultural crop improvements. The sector has evolved from traditional predictors to sophisticated evidence-guided methods utilizing machine learning and cloud-based technologies, enabling more accurate predictions. This accuracy, coupled with decreasing sequencing costs and expanded cloud capabilities, facilitates the deployment of scalable Software as a Service (SaaS) models and fosters integration with multi-omics platforms, thus driving growth and adoption across clinical and industrial sectors.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Prediction Tools market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Prediction Tools Market Segments Analysis

Global gene prediction tools market is segmented by method, application, end-use, technology integration, sales channel and region. Based on method, the market is segmented into Empirical Methods, Ab Initio Methods, Homology-Based Methods and Others. Based on application, the market is segmented into Drug Discovery and Development, Diagnostics Development, Agricultural Biotechnology and Others. Based on end-use, the market is segmented into Academic and Research Institutes, Pharmaceutical and Biotech Companies, Industrial and Agricultural Entities and Others. Based on technology integration, the market is segmented into AI and Machine Learning Enabled Tools, Standard Bioinformatic Tools and Others. Based on sales channel, the market is segmented into Direct Software Sales, Cloud-Based Service Platforms and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gene Prediction Tools Market

The Global Gene Prediction Tools market is being driven by significant advancements in machine learning algorithms that enhance the precision of gene prediction tools in identifying coding regions, splice sites, and regulatory elements. These innovations lead to improved pattern recognition and greater model generalization, thereby minimizing false positives and increasing the adaptability of models across different genomes. Furthermore, the ability to incorporate various data types, such as sequence context and evolutionary signals, enables more robust predictions. As these algorithmic enhancements continue to evolve, developers are better positioned to provide tools that align with the needs of research and clinical workflows, promoting wider adoption and integration into bioinformatics processes.

Restraints in the Global Gene Prediction Tools Market

The adoption of gene prediction tools is hindered by data privacy and regulatory challenges, as stringent standards for managing sensitive genomic information impose significant compliance demands on both developers and users. This creates uncertainty surrounding consent, data sharing, and the transfer of data across borders, causing institutions to be reluctant in implementing new predictive technologies. The necessity to comply with various legal frameworks often redirects resources away from innovation. These obligations can result in delays in product launches, complicate partnerships, and restrict access to vital datasets necessary for enhancing predictive models, ultimately obstructing market growth and development.

Market Trends of the Global Gene Prediction Tools Market

The Global Gene Prediction Tools market is increasingly influenced by the growing demand for AI explainability, which enhances trust in genomic research and clinical applications. Emphasizing model interpretability, these tools allow researchers and clinicians to comprehend decision-making processes, thereby increasing confidence in variant prioritization and therapeutic insights. This trend promotes collaboration between computational scientists and bench researchers, supports clear communication with regulatory bodies, and smoothens incorporation into diagnostic workflows. By prioritizing transparency through feature attribution and user-friendly visualizations, the perceived risks associated with black-box models are mitigated, broadening the tools' utility in both translational research and clinical outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Gene Prediction Tools Market Size by Method & CAGR (2026-2033)

• Market Overview
• Empirical Methods
• Ab Initio Methods
• Homology-Based Methods
• Others

Global Gene Prediction Tools Market Size by Application & CAGR (2026-2033)

• Market Overview
• Drug Discovery and Development
• Diagnostics Development
• Agricultural Biotechnology
• Others

Global Gene Prediction Tools Market Size by End-Use & CAGR (2026-2033)

• Market Overview
• Academic and Research Institutes
• Pharmaceutical and Biotech Companies
• Industrial and Agricultural Entities
• Others

Global Gene Prediction Tools Market Size by Technology Integration & CAGR (2026-2033)

• Market Overview
• AI and Machine Learning Enabled Tools
• Standard Bioinformatic Tools
• Others

Global Gene Prediction Tools Market Size by Sales Channel & CAGR (2026-2033)

• Market Overview
• Direct Software Sales
• Cloud-Based Service Platforms
• Others

Global Gene Prediction Tools Market Size & CAGR (2026-2033)

• North America (Method, Application, End-Use, Technology Integration, Sales Channel)
  • US
  • Canada
• Europe (Method, Application, End-Use, Technology Integration, Sales Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Method, Application, End-Use, Technology Integration, Sales Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Method, Application, End-Use, Technology Integration, Sales Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Method, Application, End-Use, Technology Integration, Sales Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• NCBI
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ensembl
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EBI (European Bioinformatics Institute)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNASTAR
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Geneious
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Softberry
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genedata
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabCorp
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 23andMe
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Counsyl
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PacBio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations